Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2018

Open Access 01-12-2018 | Research article

Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study

Authors: Sugihiro Hamaguchi, Motoi Suzuki, Kota Sasaki, Masahiko Abe, Takao Wakabayashi, Eiichiro Sando, Makito Yaegashi, Shimpei Morimoto, Norichika Asoh, Naohisa Hamashige, Masahiro Aoshima, Koya Ariyoshi, Konosuke Morimoto, on behalf of The Adult Pneumonia Study Group – Japan

Published in: BMC Pulmonary Medicine | Issue 1/2018

Login to get access

Abstract

Background

Mortality prediction of pneumonia by severity scores in patients with multiple underlying health conditions has not fully been investigated. This prospective cohort study is to identify mortality-associated underlying health conditions and to analyse their influence on severity-based pneumonia mortality prediction.

Methods

Adult patients with community-acquired pneumonia or healthcare-associated pneumonia (HCAP) who visited four community hospitals between September 2011 and January 2013 were enrolled. Candidate underlying health conditions, including demographic and clinical characteristics, were incorporated into the logistic regression models, along with CURB (confusion, elevated urea nitrogen, tachypnoea, and hypotension) score as a measure of disease severity. The areas under the receiver operating characteristic curves (AUROC) of the predictive index based on significant underlying health conditions was compared to that of CURB65 (CURB and age ≥ 65) score or Pneumonia severity index (PSI). Mortality association between disease severity and the number of underlying health conditions was analysed.

Results

In total 1772 patients were eligible for analysis, of which 140 (7.9%) died within 30 days. Six underlying health conditions were independently associated: home care (adjusted odds ratio, 5.84; 95% confidence interval, CI, 2.28–14.99), recent hospitalization (2.21; 1.36–3.60), age ≥ 85 years (2.15; 1.08–4.28), low body mass index (1.99, 1.25–3.16), neoplastic disease (1.82; 1.17–2.85), and male gender (1.78; 1.16–2.75). The predictive index based on these conditions alone had a significantly or marginally higher AUROC than that based on CURB65 score (0.78 vs 0.66, p = 0.02) or PSI (0.78 vs 0.71, p = 0.05), respectively. Compared to this index, the AUROC of the total score consisting of six underlying health conditions and CURB score (range 0–10) did not improve mortality predictions (p = 0.3). In patients with one or less underlying health conditions, the mortality was discretely associated with severe pneumonia (CURB65 ≥ 3) (risk ratio: 7.24, 95%CI: 3.08–25.13), whereas in patients with 2 or more underlying health conditions, the mortality association with severe pneumonia was not detected (risk ratio: 1.53, 95% CI: 0.94–2.50).

Conclusions

Mortality prediction based on pneumonia severity scores is highly influenced by the accumulating number of underlying health conditions in an ageing society. The validation using a different cohort is necessary to generalise the conclusion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–50.CrossRefPubMed Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–50.CrossRefPubMed
2.
go back to reference Thomas CP, Ryan M Fau - Chapman JD, Chapman Jd Fau - Stason WB, Stason Wb Fau - Tompkins CP, Tompkins Cp Fau - Suaya JA, Suaya ja Fau - Polsky D, Polsky D Fau - Mannino DM, Mannino Dm Fau - Shepard DS, Shepard DS: Incidence and cost of pneumonia in medicare beneficiaries. Chest 2012, 142(4):973–981. Thomas CP, Ryan M Fau - Chapman JD, Chapman Jd Fau - Stason WB, Stason Wb Fau - Tompkins CP, Tompkins Cp Fau - Suaya JA, Suaya ja Fau - Polsky D, Polsky D Fau - Mannino DM, Mannino Dm Fau - Shepard DS, Shepard DS: Incidence and cost of pneumonia in medicare beneficiaries. Chest 2012, 142(4):973–981.
4.
go back to reference Wunderink RG. CAP death: what goes wrong when everything is right? Lancet Infect Dis. 2015;15(9):995–6.CrossRefPubMed Wunderink RG. CAP death: what goes wrong when everything is right? Lancet Infect Dis. 2015;15(9):995–6.CrossRefPubMed
5.
go back to reference Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrus A, Menendez R, Mensa J, Blasi F, Torres A. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest. 2013;144(3):999–1007.CrossRefPubMed Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrus A, Menendez R, Mensa J, Blasi F, Torres A. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest. 2013;144(3):999–1007.CrossRefPubMed
6.
go back to reference Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med. 2002;162(9):1059–64.CrossRefPubMed Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, Fine MJ. Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med. 2002;162(9):1059–64.CrossRefPubMed
7.
go back to reference Jackson ML, Nelson JC, Jackson LA. Risk factors for community-acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc. 2009;57(5):882–8.CrossRefPubMed Jackson ML, Nelson JC, Jackson LA. Risk factors for community-acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc. 2009;57(5):882–8.CrossRefPubMed
8.
go back to reference Komiya K, Ishii H, Umeki K, Mizunoe S, Okada F, Johkoh T, Kadota J. Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study. Respirology (Carlton, Vic). 2013;18(3):514–21.CrossRef Komiya K, Ishii H, Umeki K, Mizunoe S, Okada F, Johkoh T, Kadota J. Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study. Respirology (Carlton, Vic). 2013;18(3):514–21.CrossRef
9.
go back to reference Meyer KC. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med. 2010;31(5):561–74.CrossRefPubMed Meyer KC. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med. 2010;31(5):561–74.CrossRefPubMed
10.
go back to reference Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19–26.CrossRefPubMed Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19–26.CrossRefPubMed
11.
go back to reference Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–50.CrossRefPubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–50.CrossRefPubMed
12.
go back to reference Lim WS, Van der Eerden Mm Fau - Laing R, Laing R Fau - Boersma WG, Boersma Wg Fau - Karalus N, Karalus N Fau - Town GI, Town Gi Fau - Lewis SA, Lewis Sa Fau - Macfarlane JT, Macfarlane JT: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(0040–6376 (Print)):377–382. Lim WS, Van der Eerden Mm Fau - Laing R, Laing R Fau - Boersma WG, Boersma Wg Fau - Karalus N, Karalus N Fau - Town GI, Town Gi Fau - Lewis SA, Lewis Sa Fau - Macfarlane JT, Macfarlane JT: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(0040–6376 (Print)):377–382.
13.
go back to reference Espana PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174(11):1249–56.CrossRefPubMed Espana PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174(11):1249–56.CrossRefPubMed
14.
go back to reference Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008;47(3):375–84.CrossRefPubMed Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008;47(3):375–84.CrossRefPubMed
15.
go back to reference Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, Abe M, Aoshima M, Ariyoshi K, Adult Pneumonia Study G-J. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10(3):e0122247.CrossRefPubMedPubMedCentral Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, Abe M, Aoshima M, Ariyoshi K, Adult Pneumonia Study G-J. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10(3):e0122247.CrossRefPubMedPubMedCentral
18.
go back to reference Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee. MMWR Recomm Rep. 2004;53(RR-3):1–36.PubMed Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the healthcare infection control practices advisory committee. MMWR Recomm Rep. 2004;53(RR-3):1–36.PubMed
19.
go back to reference The American Thoracic Society TIDSoA. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.CrossRef The American Thoracic Society TIDSoA. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.CrossRef
20.
go back to reference Sligl WI, Majumdar SR. How important is age in defining the prognosis of patients with community-acquired pneumonia? Curr Opin Infect Dis. 2011;24(2):142–7.CrossRefPubMed Sligl WI, Majumdar SR. How important is age in defining the prognosis of patients with community-acquired pneumonia? Curr Opin Infect Dis. 2011;24(2):142–7.CrossRefPubMed
21.
go back to reference Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766–72.CrossRefPubMed Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766–72.CrossRefPubMed
23.
go back to reference Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, Jackson R, Schousboe M, Frampton C, Hutton S, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010–6.CrossRefPubMedPubMedCentral Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, Jackson R, Schousboe M, Frampton C, Hutton S, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010–6.CrossRefPubMedPubMedCentral
24.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.CrossRefPubMed
25.
go back to reference Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Obrosky DS. Community-acquired pneumonia and do not resuscitate orders. J Am Geriatr Soc. 2002;50(2):290–9.CrossRefPubMed Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Obrosky DS. Community-acquired pneumonia and do not resuscitate orders. J Am Geriatr Soc. 2002;50(2):290–9.CrossRefPubMed
26.
go back to reference Kwok CS, Loke YK, Woo K, Myint PK: Risk prediction models for mortality in community-acquired pneumonia: a systematic review. Bio Med research international 2013, 2013:504136. Kwok CS, Loke YK, Woo K, Myint PK: Risk prediction models for mortality in community-acquired pneumonia: a systematic review. Bio Med research international 2013, 2013:504136.
27.
go back to reference Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC, Lee SH, Lee CC. Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax. 2010;65(11):971–7.CrossRefPubMed Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC, Lee SH, Lee CC. Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. Thorax. 2010;65(11):971–7.CrossRefPubMed
28.
go back to reference Arnold FW, Wiemken TL, Peyrani P, Mirsaeidi M, Ramirez JA. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males. Eur Respir J. 2013;41(5):1135–40.CrossRefPubMed Arnold FW, Wiemken TL, Peyrani P, Mirsaeidi M, Ramirez JA. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males. Eur Respir J. 2013;41(5):1135–40.CrossRefPubMed
29.
go back to reference Rello J, Lujan M, Gallego M, Valles J, Belmonte Y, Fontanals D, Diaz E, Lisboa T. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest. 2010;137(5):1138–44.CrossRefPubMed Rello J, Lujan M, Gallego M, Valles J, Belmonte Y, Fontanals D, Diaz E, Lisboa T. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest. 2010;137(5):1138–44.CrossRefPubMed
30.
go back to reference Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014;58(3):330–9.CrossRefPubMed Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014;58(3):330–9.CrossRefPubMed
31.
go back to reference Fine MJ, Orloff JJ, Arisumi D, Fang GD, Arena VC, Hanusa BH, Yu VL, Singer DE, Kapoor WN. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med. 1990;88(5N):1N–8N.PubMed Fine MJ, Orloff JJ, Arisumi D, Fang GD, Arena VC, Hanusa BH, Yu VL, Singer DE, Kapoor WN. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med. 1990;88(5N):1N–8N.PubMed
32.
go back to reference Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J. 2011;37(6):1439–46.CrossRefPubMed Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J. 2011;37(6):1439–46.CrossRefPubMed
33.
go back to reference Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54(8):774–781. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54(8):774–781.
Metadata
Title
Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study
Authors
Sugihiro Hamaguchi
Motoi Suzuki
Kota Sasaki
Masahiko Abe
Takao Wakabayashi
Eiichiro Sando
Makito Yaegashi
Shimpei Morimoto
Norichika Asoh
Naohisa Hamashige
Masahiro Aoshima
Koya Ariyoshi
Konosuke Morimoto
on behalf of The Adult Pneumonia Study Group – Japan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0648-y

Other articles of this Issue 1/2018

BMC Pulmonary Medicine 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.